Literature DB >> 23730168

Gentamicin in neonates at risk for sepsis - peak serum concentrations are not necessary.

Luke F Reynolds1, Timothy L Mailman, Douglas D McMillan.   

Abstract

BACKGROUND: Serum gentamicin concentrations (GSCs) are frequently obtained before and after gentamicin administration to newborns with, or at high risk for, sepsis.
OBJECTIVE: To determine whether performing a peak GSC assay when the trough GSC is within the guidelines for care would add clinically relevant information for health care workers.
METHODS: A retrospective review of the IWK Health Centre (Halifax, Nova Scotia) laboratory database for peak and trough GSC for infants <28 days after birth was performed.
RESULTS: Of 5253 paired samples of trough and peak GSCs, 3001 (57%) had trough GSCs ≤2 μg/mL. Of these, only nine (0.3%) had a peak GSC >10 μg/mL.
CONCLUSIONS: Performing a peak GSC measurement does not provide further clinically important data and increases patient morbidity and hospital costs.

Entities:  

Keywords:  Aminoglycoside; Cost-effectiveness; Dosing; Gentamicin; Neonate; Toxicity

Year:  2012        PMID: 23730168      PMCID: PMC3380747     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  28 in total

1.  Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or = 2500 g.

Authors:  Ghanshyam Agarwal; Alok Rastogi; Suma Pyati; Angela Wilks; Rosita S Pildes
Journal:  J Perinatol       Date:  2002-06       Impact factor: 2.521

2.  Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use.

Authors:  Stephanie J Schrag; James L Hadler; Kathryn E Arnold; Patricia Martell-Cleary; Arthur Reingold; Anne Schuchat
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

3.  A controlled study of the nephrotoxicity of mezlocillin and amikacin in the neonate.

Authors:  R D Adelman; F Wirth; T Rubio
Journal:  Am J Dis Child       Date:  1987-11

Review 4.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 5.  Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.

Authors:  E Nestaas; H-J Bangstad; L Sandvik; K-O Wathne
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-27       Impact factor: 5.747

6.  Risk factors for early onset neonatal group B streptococcal sepsis: case-control study.

Authors:  Sam Oddie; Nicholas D Embleton
Journal:  BMJ       Date:  2002-08-10

7.  Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides.

Authors:  G C Yee; W E Evans
Journal:  Pharmacotherapy       Date:  1981 Jul-Aug       Impact factor: 4.705

8.  Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.

Authors:  David S Hoff; Roger A Wilcox; Lisa M Tollefson; Polina G Lipnik; Amy R Commers; Meixia Liu
Journal:  Pharmacotherapy       Date:  2009-11       Impact factor: 4.705

Review 9.  Venepuncture versus heel lance for blood sampling in term neonates.

Authors:  V Shah; A Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  [Gentamicin dosage in newborn infants].

Authors:  R Sommer; F Eitelberger; L Hohenauer
Journal:  Klin Padiatr       Date:  1989 Sep-Oct       Impact factor: 1.349

View more
  2 in total

1.  Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example.

Authors:  Tomas Radivoyevitch; Nopphon Siranart; Lynn Hlatky; Rainer Sachs
Journal:  AAPS J       Date:  2015-02-07       Impact factor: 4.009

2.  Should gentamicin trough levels be routinely obtained in term neonates?

Authors:  J Ibrahim; D Maffei; G El-Chaar; S Islam; S Ponnaiya; A Nayak; W Rosenfeld; N Hanna
Journal:  J Perinatol       Date:  2016-08-18       Impact factor: 2.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.